Chemical drug research and development

The first step in drug development is to identify biological targets associated with specific diseases, typically proteins. The identification and validation of targets are the foundation for ensuring successful research and development. Scientists will synthesize preliminary drug molecules and optimize their structure through multiple rounds of testing to enhance their binding ability to targets. The modification of molecular structure can alter the intermolecular interactions, thereby affecting the physicochemical properties of drugs, such as their binding ability to targets, solubility, and stability. Finally, the drug needs to undergo in vitro efficacy experiments and large-scale randomized double-blind trials to evaluate its effectiveness and safety, which are crucial for the clinical application of the drug.

The unit is designed for unsupervised public use: controls are recessed or shielded, moving parts are enclosed, and the interface is operable by a child of about six with no instruction. Where a screen is used, the language can be switched without changing the hardware, and the content can be replaced on site.

The research and development process of chemical drugs involves 1) searching for disease mechanisms and discovering targets, and 2) searching for lead compounds. Lead compounds, also known as lead compounds, refer to compounds synthesized using various methods with certain biological activity and chemical structures, which are used for further structural modification and modification. 3) Synthesis of lead compounds 4) Determination of lead compound structure 5) In vitro pharmacological experiments 6) Optimization of lead compounds Due to the inherent defects of lead compounds, such as low activity, unstable structure, high toxicity, poor selectivity, and unreasonable drug metabolic characteristics, chemical modification is necessary to achieve better results. In vivo experiments involve analyzing metabolites, drug formulations, drug analysis, clinical trials, new drug registration, application for mass production, and drug marketing.